Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Mental Dysfunction in Parkinson's Disease
Article type: Review Article
Authors: Geurtsen, Gert J. | Hoogland, Jeroen | Goldman, Jennifer G. | Schmand, Ben A.; | Tröster, Alexander I. | Burn, David J. | Litvan, Irene | on behalf of the MDS Study group on the validation of PD-MCI criteria
Affiliations: Department of Neurology, Academic Medical Center Amsterdam, The Netherlands | Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA | Department of Psychology, University of Amsterdam, The Netherlands | Barrow Neurological Institute, Muhammad Ali Parkinson Center, Phoenix, AZ, USA | Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, UK | Department of Neurosciences University of California, Movement Disorder Center, San Diego, CA, USA
Note: [] Correspondence to: Gert J. Geurtsen, PhD, Department of Neurology, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, The Netherlands. Tel.: +31 20 5663590; Fax: +31 20 5669217; E-mail: g.j.geurtsen@amc.uva.nl
Abstract: Dementia in Parkinson's disease (PD) is a serious health issue and a major concern for many patients. In most cases mild cognitive impairment (MCI) is considered a transitional stage between normal cognitive functioning and dementia which is of potential importance in the early identification of patients at risk for dementia. Recently, the Movement Disorder Society (MDS) proposed diagnostic criteria for MCI in PD (PD-MCI). These criteria comprise two operationalizations: Level I (based on an abbreviated assessment) and Level II (based on comprehensive neuropsychological evaluation permitting MCI subtyping). These criteria need to be validated. This paper describes a project aiming to validate the MDS PD-MCI criteria by pooling and analyzing cross-sectional and longitudinal neuropsychological databases comprising ≥5,500 PD patients and ≥1,700 controls. After applying the MDS PD-MCI Level I and Level II criteria, rates of conversion to PD-dementia and predictive variables for conversion to PD-dementia will be established. This study will also assist in identifying whether revisions of the PD-MCI criteria are required.
Keywords: Parkinson disease, mild cognitive impairment, neuropsychological tests/standards, dementia, validation studies
DOI: 10.3233/JPD-130304
Journal: Journal of Parkinson's Disease, vol. 4, no. 2, pp. 131-137, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl